SBIR Phase II: Large-scale, high-throughput optimization of gene expression in industrial yeast for improved small molecule production

SBIR II 期：大规模、高通量优化工业酵母中的基因表达，以改善小分子生产

• 批准号: 1456071
• 负责人: Andrew Conley
• 金额: $ 75万
• 依托单位: Lygos Inc.
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-03-01 至 2020-10-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1456071&HistoricalAwards=false
• 关键词: SBIR; Phase; II; Large; scale

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is development of a microbial technology for the conversion of low-value sugars into high-value chemicals. Most industrial chemicals produced today are derived from petroleum and other nonrenewable raw materials. The long-term growth and sustainability of the chemical industry benefits from development of new routes to existing chemicals using renewable raw materials. Furthermore, due to higher infrastructure costs and stricter environmental requirements, many chemicals that were once produced in the United States are now produced abroad. This contributes to the U.S. trade deficit. This Phase II proposal aims to develop a fermentation technology where domestically grown agricultural materials (for example, corn and waste agricultural residues) are converted into high-value chemicals. The optimized fermentation process is estimated to be cost-competitive with the incumbent petrochemical route when scaled. If successful, this proposal will facilitate growth of a domestic bio-chemical manufacturing industry, targeting the $30 billion organic acids market.This SBIR Phase II project proposes to develop large-scale, high-throughput techniques to optimize gene expression in industrial yeast. A significant problem within the field of industrial biotechnology is the ability to engineer and optimize the fermentation performance of non-academic or model microbes. Most molecular metabolic engineering tools are developed for use in two model prokaryotic and eukaryotic microbes, E. coli and S. cerevisiae, and are not suitable for use with industrially relevant microbes. Without these tools it is costly and slow to commercialize new fermentation technologies. The goal of this Phase II project is to develop and implement a set of molecular biology tools designed for acid-tolerant yeast, and working to apply them toward improving small molecule production. Specifically, the molecular biology tools are useful for tuning (up- or down-regulation) user-defined gene transcription and translation. Engineered microbes harboring the desired genetic modification(s) are assayed for improved small molecule production from sugar in small scale fermentations. Successful genetic modifications are those that result in more efficient small molecule product formation from sugar, and ideally decreased biomass formation from sugar, providing a lower production cost in a scaled, commercial process.

这个小企业创新研究（SBIR）第二阶段项目的更广泛影响/商业潜力是开发一种微生物技术，将低价值的糖转化为高价值的化学品。今天生产的大多数工业化学品都是从石油和其他不可再生的原材料中提取的。化学工业的长期增长和可持续性得益于使用可再生原材料开发现有化学品的新途径。此外，由于基础设施成本更高，环境要求更严格，许多曾经在美国生产的化学品现在都在国外生产。这导致了美国的贸易逆差。该第二阶段提案旨在开发一种发酵技术，将国内种植的农业材料（例如玉米和农业废弃物）转化为高价值化学品。经优化的发酵工艺在规模化生产时，与现有的石化路线相比，估计具有成本竞争力。如果成功的话，该项目将促进国内生物化学制造业的发展，目标是300亿美元的有机酸市场。SBIR二期项目旨在开发大规模、高通量的技术，以优化工业酵母中的基因表达。在工业生物技术领域内的一个重要问题是工程设计和优化非学术或模型微生物的发酵性能的能力。大多数分子代谢工程工具是为用于两种模型原核和真核微生物而开发的。coli和革兰氏阳性菌S.酿酒酵母，并且不适合与工业上相关的微生物一起使用。如果没有这些工具，新的发酵技术的商业化将是昂贵和缓慢的。该项目的第二阶段的目标是开发和实施一套针对耐酸酵母设计的分子生物学工具，并致力于将其应用于提高小分子生产。具体地，分子生物学工具可用于调节（上调或下调）用户定义的基因转录和翻译。对含有所需遗传修饰的工程化微生物在小规模发酵中从糖生产小分子的改进进行了分析。成功的遗传修饰是那些导致从糖更有效地形成小分子产物，并且理想地减少从糖形成生物质，从而在规模化的商业化方法中提供更低生产成本的遗传修饰。